ImmuCell Corporation (ICCC)
NASDAQ · Healthcare
ImmuCell Corporation Long Term Debt 2017–2025
ImmuCell Corporation annual long term debt history from 2017 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- ImmuCell Corporation long term debt as of December 31, 2025: 9.1M, a 0.64% increase year-over-year.
- ImmuCell Corporation long term debt for 2025 were 9.1M, a 0.64% increase from 2024.
- ImmuCell Corporation long term debt for 2024 were 9.0M, a 11.63% decrease from 2022.
- ImmuCell Corporation long term debt for 2022 were 10.2M, a 1159.60% increase from 2021.
- ImmuCell Corporation long term debt for 2021 were 812,207.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| ImmuCell Corporation Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $9 |
| 2024 | $9 |
| 2022 | $10 |
| 2021 | $1 |
| 2020 | $9 |
| 2019 | $8 |
| 2018 | $9 |
| 2017 | $9 |
ImmuCell Corporation Long Term Debt — FAQ
ImmuCell Corporation (ICCC) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ICCC's long term debt history?
The chart and table above show ImmuCell Corporation's long term debt by year and by quarter, including the growth rate.